866-997-4948(US-Canada Toll Free)

United States Psoriasis Drugs Market Report 2018

Published By :

QYResearch

Published Date : Jun 2018

Category :

Pharmaceutical

No. of Pages : 95 Pages

In this report, the United States Psoriasis Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Psoriasis Drugs in these regions, from 2013 to 2025 (forecast).

United States Psoriasis Drugs market competition by top manufacturers/players, with Psoriasis Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
AbbVie
Amgen
Johnson & Johnson
Novartis
Eli Lilly
AstraZeneca
Celgene
...

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
TNF-inhibitors
Interleukin-inhibitors
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospital
Clinic

Table of Contents

United States Psoriasis Drugs Market Report 2018
1 Psoriasis Drugs Overview
1.1 Product Overview and Scope of Psoriasis Drugs
1.2 Classification of Psoriasis Drugs by Product Category
1.2.1 United States Psoriasis Drugs Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Psoriasis Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 TNF-inhibitors
1.2.4 Interleukin-inhibitors
1.2.5 Others
1.3 United States Psoriasis Drugs Market by Application/End Users
1.3.1 United States Psoriasis Drugs Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Hospital
1.3.3 Clinic
1.4 United States Psoriasis Drugs Market by Region
1.4.1 United States Psoriasis Drugs Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Psoriasis Drugs Status and Prospect (2013-2025)
1.4.3 Southwest Psoriasis Drugs Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Psoriasis Drugs Status and Prospect (2013-2025)
1.4.5 New England Psoriasis Drugs Status and Prospect (2013-2025)
1.4.6 The South Psoriasis Drugs Status and Prospect (2013-2025)
1.4.7 The Midwest Psoriasis Drugs Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Psoriasis Drugs (2013-2025)
1.5.1 United States Psoriasis Drugs Sales and Growth Rate (2013-2025)
1.5.2 United States Psoriasis Drugs Revenue and Growth Rate (2013-2025)

2 United States Psoriasis Drugs Market Competition by Players/Suppliers
2.1 United States Psoriasis Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Psoriasis Drugs Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Psoriasis Drugs Average Price by Players/Suppliers (2013-2018)
2.4 United States Psoriasis Drugs Market Competitive Situation and Trends
2.4.1 United States Psoriasis Drugs Market Concentration Rate
2.4.2 United States Psoriasis Drugs Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Psoriasis Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 United States Psoriasis Drugs Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Psoriasis Drugs Sales and Market Share by Region (2013-2018)
3.2 United States Psoriasis Drugs Revenue and Market Share by Region (2013-2018)
3.3 United States Psoriasis Drugs Price by Region (2013-2018)

4 United States Psoriasis Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Psoriasis Drugs Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Psoriasis Drugs Revenue and Market Share by Type (2013-2018)
4.3 United States Psoriasis Drugs Price by Type (2013-2018)
4.4 United States Psoriasis Drugs Sales Growth Rate by Type (2013-2018)

5 United States Psoriasis Drugs Sales (Volume) by Application (2013-2018)
5.1 United States Psoriasis Drugs Sales and Market Share by Application (2013-2018)
5.2 United States Psoriasis Drugs Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 United States Psoriasis Drugs Players/Suppliers Profiles and Sales Data
6.1 AbbVie
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Psoriasis Drugs Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 AbbVie Psoriasis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Amgen
6.2.2 Psoriasis Drugs Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Amgen Psoriasis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Johnson & Johnson
6.3.2 Psoriasis Drugs Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Johnson & Johnson Psoriasis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Novartis
6.4.2 Psoriasis Drugs Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Novartis Psoriasis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Eli Lilly
6.5.2 Psoriasis Drugs Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Eli Lilly Psoriasis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 AstraZeneca
6.6.2 Psoriasis Drugs Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 AstraZeneca Psoriasis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Celgene
6.7.2 Psoriasis Drugs Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Celgene Psoriasis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
...

7 Psoriasis Drugs Manufacturing Cost Analysis
7.1 Psoriasis Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Psoriasis Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Psoriasis Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Psoriasis Drugs Major Manufacturers in 2017
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Psoriasis Drugs Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States Psoriasis Drugs Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Psoriasis Drugs Sales Volume Forecast by Type (2018-2025)
11.3 United States Psoriasis Drugs Sales Volume Forecast by Application (2018-2025)
11.4 United States Psoriasis Drugs Sales Volume Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer

List of Table

List of Tables and Figures

Figure Product Picture of Psoriasis Drugs
Figure United States Psoriasis Drugs Market Size (K Units) by Type (2013-2025)
Figure United States Psoriasis Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure TNF-inhibitors Product Picture
Figure Interleukin-inhibitors Product Picture
Figure Others Product Picture
Figure United States Psoriasis Drugs Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Psoriasis Drugs by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure United States Psoriasis Drugs Market Size (Million USD) by Region (2013-2025)
Figure The West Psoriasis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Psoriasis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Psoriasis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Psoriasis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Psoriasis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Psoriasis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Psoriasis Drugs Sales (K Units) and Growth Rate (2013-2025)
Figure United States Psoriasis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Psoriasis Drugs Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Psoriasis Drugs Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Psoriasis Drugs Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Psoriasis Drugs Sales Share by Players/Suppliers
Figure 2017 United States Psoriasis Drugs Sales Share by Players/Suppliers
Figure United States Psoriasis Drugs Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Psoriasis Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Psoriasis Drugs Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Psoriasis Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Psoriasis Drugs Revenue Share by Players/Suppliers
Table United States Market Psoriasis Drugs Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Psoriasis Drugs Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Psoriasis Drugs Market Share of Top 3 Players/Suppliers
Figure United States Psoriasis Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Psoriasis Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Psoriasis Drugs Product Category
Table United States Psoriasis Drugs Sales (K Units) by Region (2013-2018)
Table United States Psoriasis Drugs Sales Share by Region (2013-2018)
Figure United States Psoriasis Drugs Sales Share by Region (2013-2018)
Figure United States Psoriasis Drugs Sales Market Share by Region in 2017
Table United States Psoriasis Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Psoriasis Drugs Revenue Share by Region (2013-2018)
Figure United States Psoriasis Drugs Revenue Market Share by Region (2013-2018)
Figure United States Psoriasis Drugs Revenue Market Share by Region in 2017
Table United States Psoriasis Drugs Price (USD/Unit) by Region (2013-2018)
Table United States Psoriasis Drugs Sales (K Units) by Type (2013-2018)
Table United States Psoriasis Drugs Sales Share by Type (2013-2018)
Figure United States Psoriasis Drugs Sales Share by Type (2013-2018)
Figure United States Psoriasis Drugs Sales Market Share by Type in 2017
Table United States Psoriasis Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Psoriasis Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Psoriasis Drugs by Type (2013-2018)
Figure Revenue Market Share of Psoriasis Drugs by Type in 2017
Table United States Psoriasis Drugs Price (USD/Unit) by Types (2013-2018)
Figure United States Psoriasis Drugs Sales Growth Rate by Type (2013-2018)
Table United States Psoriasis Drugs Sales (K Units) by Application (2013-2018)
Table United States Psoriasis Drugs Sales Market Share by Application (2013-2018)
Figure United States Psoriasis Drugs Sales Market Share by Application (2013-2018)
Figure United States Psoriasis Drugs Sales Market Share by Application in 2017
Table United States Psoriasis Drugs Sales Growth Rate by Application (2013-2018)
Figure United States Psoriasis Drugs Sales Growth Rate by Application (2013-2018)
Table AbbVie Basic Information List
Table AbbVie Psoriasis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AbbVie Psoriasis Drugs Sales Growth Rate (2013-2018)
Figure AbbVie Psoriasis Drugs Sales Market Share in United States (2013-2018)
Figure AbbVie Psoriasis Drugs Revenue Market Share in United States (2013-2018)
Table Amgen Basic Information List
Table Amgen Psoriasis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen Psoriasis Drugs Sales Growth Rate (2013-2018)
Figure Amgen Psoriasis Drugs Sales Market Share in United States (2013-2018)
Figure Amgen Psoriasis Drugs Revenue Market Share in United States (2013-2018)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Psoriasis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Johnson & Johnson Psoriasis Drugs Sales Growth Rate (2013-2018)
Figure Johnson & Johnson Psoriasis Drugs Sales Market Share in United States (2013-2018)
Figure Johnson & Johnson Psoriasis Drugs Revenue Market Share in United States (2013-2018)
Table Novartis Basic Information List
Table Novartis Psoriasis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Psoriasis Drugs Sales Growth Rate (2013-2018)
Figure Novartis Psoriasis Drugs Sales Market Share in United States (2013-2018)
Figure Novartis Psoriasis Drugs Revenue Market Share in United States (2013-2018)
Table Eli Lilly Basic Information List
Table Eli Lilly Psoriasis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eli Lilly Psoriasis Drugs Sales Growth Rate (2013-2018)
Figure Eli Lilly Psoriasis Drugs Sales Market Share in United States (2013-2018)
Figure Eli Lilly Psoriasis Drugs Revenue Market Share in United States (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca Psoriasis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca Psoriasis Drugs Sales Growth Rate (2013-2018)
Figure AstraZeneca Psoriasis Drugs Sales Market Share in United States (2013-2018)
Figure AstraZeneca Psoriasis Drugs Revenue Market Share in United States (2013-2018)
Table Celgene Basic Information List
Table Celgene Psoriasis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Celgene Psoriasis Drugs Sales Growth Rate (2013-2018)
Figure Celgene Psoriasis Drugs Sales Market Share in United States (2013-2018)
Figure Celgene Psoriasis Drugs Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Psoriasis Drugs
Figure Manufacturing Process Analysis of Psoriasis Drugs
Figure Psoriasis Drugs Industrial Chain Analysis
Table Raw Materials Sources of Psoriasis Drugs Major Players/Suppliers in 2017
Table Major Buyers of Psoriasis Drugs
Table Distributors/Traders List
Figure United States Psoriasis Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Psoriasis Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Psoriasis Drugs Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Psoriasis Drugs Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Psoriasis Drugs Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Psoriasis Drugs Sales Volume (K Units) Forecast by Type in 2025
Table United States Psoriasis Drugs Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Psoriasis Drugs Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Psoriasis Drugs Sales Volume (K Units) Forecast by Application in 2025
Table United States Psoriasis Drugs Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Psoriasis Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Psoriasis Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Psoriasis Drugs Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *